Market header image

Filings

You are here

Home › Trading › Market Activity › Company Filings › Curaleaf - Restated Q2 2022 interim MD&A in IFRS

Curaleaf - Restated Q2 2022 interim MD&A in IFRS

May 1, 2023


CSE Listing(s):

AttachmentSize
PDF icon CURA_MDA_Q2_2022_IFRS.pdf798.13 KB

Search form